| Aug 6 |
RxSight, Inc. (RXST) Q2 2024 Earnings Call Transcript
|
| Aug 5 |
RxSight, Inc. (RXST) Reports Break-Even Earnings for Q2
|
| Aug 5 |
RxSight Non-GAAP EPS of $0.00 beats by $0.11, revenue of $34.9M beats by $2.57M
|
| Aug 5 |
RxSight, Inc. Reports Second Quarter 2024 Financial Results
|
| Jul 29 |
Down -26.04% in 4 Weeks, Here's Why RxSight (RXST) Looks Ripe for a Turnaround
|
| Jul 25 |
Exploring Undervalued Small Caps With Insider Action In The United States July 2024
|
| Jul 22 |
RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024
|
| Jul 16 |
Johnson & Johnson Q2 Earnings Preview: Can New Drugs Lift Sagging Stock?
|
| Jul 15 |
RxSight Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
|
| Jul 12 |
RxSight (RXST) Loses -16.11% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
|
